As of 3:59pm ET
| +0.07 / +1.96%|
The 4 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +187.67% increase from the last price of 3.65.
The current consensus among 4 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.